$GMAB

Genmab

  • NASDAQ
  • Health Technology
  • Medical Specialties

PRICE

$38.51 ▼-0.926%

Delayed Price

VOLUME

275,987

DAY RANGE

-

52 WEEK

26.19 - 47.5

Join Discuss about GMAB with like-minded investors

profile
@dros #droscrew
recently

Upgrades 9/16: $AXP $AZUL $BUD $CAR $CSCO $DAN $DASH $SAN $SIG Downgrades 9/16: $BYND $EQNR $FSR $GMAB $LEA $LVS $MLCO $RIDE $TBPH $UL $VC $WYNN +Initiations 9/16: $AUUD $CELH $CRNT $EZPW $GXO $HUMA $LILM $LMAT $PEN

125 Replies 12 👍 10 🔥

profile
@dros #droscrew
recently

Upgrades 9/7: $BMO $CRUS $DOOO $FIVN $MEOH $SO $SPOT $TCBK $TD $TMX $VTR . Downgrades 9/7: $AMCR $AMGN $ARGX $BANR $CARR $FTCH $GMAB $JNJ $JOAN $LNT $LRCX $MCFE $MRK $SJR $VRTX $XOMA

115 Replies 15 👍 6 🔥

Key Metrics

Market Cap

25.64 B

Beta

0.78

Avg. Volume

596.59 K

Shares Outstanding

659.62 M

Yield

0%

Public Float

0

Next Earnings Date

2023-02-22

Next Dividend Date

Company Information

Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund.

CEO: Jan van de Winkel

Website:

HQ: Kalvebod Brygge 43, 1560 Koebenhavn V

Related News